S-Space

Browse

Author

Showing results 1 to 3 of 3

Issue Date	Title / Author(s) / Citation	File
2011-12	Phase II study of sunitinib as second-line treatment for advanced gastric cancer Bang, Yung-Jue; Kang, Yoon-Koo; Kang, Won K.; Boku, Narikazu; Chung, Hyun C.; Chen, Jen-Shi; Doi, Toshihiko; Sun, Yan; Shen, Lin; Qin, Shukui; Ng, Wai-Tong; Tursi, Jennifer M.; Lechuga, Maria J.; Lu, Dongrui Ray; Ruiz-Garcia, Ana; Sobrero, Alberto Investigational New Drugs, Vol.29 No.6, pp.1449-1458	DOI
2017-06	Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial Chu, Michael P.; Hecht, J. Randolph; Slamon, Dennis; Wainberg, Zev A.; Bang, Yung-Jue; Hoff, Paulo M.; Sobrero, Alberto; Qin, Shukui; Afenjar, Karen; Houe, Vincent; King, Karen; Koski, Sheryl; Mulder, Karen; Hiller, Julie Price; Scarfe, Andrew; Spratlin, Jennifer; Huang, Yingjie J.; Khan-Wasti, Saba; Chua, Neil; Sawyer, Michael B. JAMA oncology, Vol.3 No.6, pp.767-773	DOI
2017-12	Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial Bang, Yung-Jue; Xu, Rui-Hua; Chin, Keisho; Lee, Keun-Wook; Park, Se Hoon; Rha, Sun Young; Shen, Lin; Qin, Shukui; Xu, Nong; Im, Seock-Ah; Locker, Gershon; Rowe, Phil; Shi, Xiaojin; Hodgson, Darren; Liu, Yu-Zhen; Boku, Narikazu The Lancet Oncology, Vol.18 No.12, pp.1637-1651	DOI